Michigan State University | Department of Neurology

Research site

(Unclaimed)

Location

804 Service Road, Suite A212 Clinical Center, East Lansing, Michigan, United States of America

Site insights

Top conditions

Top treatments

Cyclophosphamide

Etoposide

Carboplatin

Vincristine Sulfate

Bapineuzumab

Doxorubicin Hydrochloride

Levodopa

cyclophosphamide

Cisplatin

Carbidopa

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 210 total trials

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

This phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that...

Active, not recruiting

Desmoid Fibromatosis

Unresectable Desmoid Fibromatosis

Drug: Nirogacestat

Procedure: Echocardiography Test

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered...

Enrolling

Parkinson Disease

Drug: AAV2-GDNF gene therapy

Procedure: control surgery

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling

Ischemic Stroke; Ischemic Attack, Transient

Drug: Placebo

Drug: Milvexian

An Open-label Study of XEN1101 in Epilepsy (X-TOLE4)

This study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FO...

Invitation-only

Tonic-Clonic Seizures

Focal Epilepsy

Drug: XEN1101

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experiment...

Active, not recruiting

Triple Negative Breast Cancer

Drug: Atezolizumab

Drug: Placebo

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)

This is a multi-center, randomized, double-blind, double-dummy, active controlled clinical Study. Following a screening period, eligible subjects wil...

Active, not recruiting

Parkinson's Disease

Drug: Placebo for Oral IR-LD/CD

Drug: Oral IR-LD/CD

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

The primary objective is to understand the utility of Personal KinetiGraph movement recording system data in the clinical management of Parkinson's d...

Active, not recruiting

Parkinson Disease

Device: Personal KinetiGraph™ (PKG™)

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linez...

Enrolling

Diabetic Foot Infection

Drug: contezolid acefosamil (IV)/contezolid (PO)

Drug: Linezolid (IV and PO)